| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6B | $3.7B | $3.8B | $3.7B | $3.7B | $3.2B | $0.8B | $3.1B |
| Cost of Revenue | $1.1B | $1.3B | $1.5B | $1.6B | $1.6B | $1.4B | $1.5B | $1.4B |
| Gross Profit | $2.5B | $2.4B | $2.3B | $2.1B | $2.0B | $1.8B | $0.5B | $1.7B |
| R&D Expense | $0.6B | $0.7B | $0.7B | $0.5B | $0.5B | $0.5B | $0.5B | $0.4B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.6B | $0.5B | $0.4B | $0.5B | $0.6B | $0.4B | $0.4B | $0.3B |
| Net Income | $0.4B | $1.5B | $0.3B | $0.4B | $0.5B | $0.4B | $0.3B | $0.3B |
| EPS (Basic) | $1.77 | $6.13 | $1.26 | $1.81 | $1.96 | $1.56 | $1.12 | $1.13 |
| EPS (Diluted) | $1.76 | $6.09 | $1.25 | $1.80 | $1.94 | $1.55 | $1.11 | $1.12 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.3B | $9.5B | $9.5B | $7.3B | $7.1B | $6.9B | $6.6B | $5.8B |
| Current Assets | $1.6B | $2.3B | $1.8B | $1.5B | $1.5B | $1.3B | $1.2B | $1.1B |
| Cash & Equivalents | $0.3B | $0.7B | $0.2B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| Total Liabilities | $3.5B | $3.7B | $5.0B | $3.2B | $3.2B | $3.3B | $3.5B | $3.1B |
| Current Liabilities | $1.5B | $1.8B | $1.8B | $1.5B | $1.2B | $1.3B | $1.2B | $1.1B |
| Stockholders' Equity | $5.8B | $5.7B | $4.5B | $4.1B | $3.9B | $3.6B | $3.1B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.5B | $0.6B | $0.4B | $0.8B | $0.7B | $0.6B | — |
| Investing Cash Flow | $-0.0B | $1.9B | $-2.1B | $-0.2B | $-0.2B | $-0.2B | $-0.3B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-0.9B | $-1.9B | $1.4B | $-0.2B | $-0.4B | $-0.4B | $-0.3B | — |